Ucp3 genes
CA 2303003 A1 · Owner: Amaral, M. Catherine · Inventors: Zhang, Ning; Chen, Jin-Long; Amaral, M. Catherine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods and compositions relating to a novel family of genes, mUCP3s, involved in metabolic regulation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed mUCP3 encoding nucleic acids or purified from mammalian cells. The invention provides isolated mUCP3 hybridization probes knock-out/in constructs and , primers capable of specifically hybridizing with the disclosed mUCP3 genes mUCP3-specific binding agents such as specific antibodies animals and cells , modified with the subject mUCP3 nucleic acids and methods of making and using , the subject compositions in the biopharmaceutical industry.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 25, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.